ERBB2 and breast carcinoma: FGFR4 was specifically selected as a gene overexpressed in HER2ENC7, but it displays a lesser correlation to ERBB2, a prototypical HER2ENC gene, in SCAN-B data but also TCGA breast cancers when analyzed through the cBioPortal online tool (Spearman rho = 0.24).